170 related articles for article (PubMed ID: 33957930)
21. Inter- and Intra-individual Variation, and Limited Prognostic Utility, of Serum Alkaline Phosphatase in a Trial of Patients With Primary Sclerosing Cholangitis.
Trivedi PJ; Muir AJ; Levy C; Bowlus CL; Manns MP; Lu X; Crans G; Chung C; Subramanian GM; Myers RP; Goodman Z; Chalasani N; Vierling JM; Guha IN; Hirschfield GM
Clin Gastroenterol Hepatol; 2021 Jun; 19(6):1248-1257. PubMed ID: 32707342
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing Cholangitis.
Gauss A; Sauer P; Stiehl A; Rupp C; Krisam J; Leopold Y; Kloeters-Plachky P; Stremmel W; Gotthardt D
Medicine (Baltimore); 2016 Apr; 95(17):e3510. PubMed ID: 27124059
[TBL] [Abstract][Full Text] [Related]
23. Primary sclerosing cholangitis in Turkish patients: characteristic features and prognosis.
Ataseven H; Parlak E; Yüksel I; Başar O; Ertuğrul I; Saşmaz N; Sahin B
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):312-5. PubMed ID: 19502174
[TBL] [Abstract][Full Text] [Related]
24. Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases.
Lynch KD; Chapman RW; Keshav S; Montano-Loza AJ; Mason AL; Kremer AE; Vetter M; de Krijger M; Ponsioen CY; Trivedi P; Hirschfield G; Schramm C; Liu CH; Bowlus CL; Estes DJ; Pratt D; Hedin C; Bergquist A; de Vries AC; van der Woude CJ; Yu L; Assis DN; Boyer J; Ytting H; Hallibasic E; Trauner M; Marschall HU; Daretti LM; Marzioni M; Yimam KK; Perin N; Floreani A; Beretta-Piccoli BT; Rogers JK; ; Levy C
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):179-187.e6. PubMed ID: 31100458
[TBL] [Abstract][Full Text] [Related]
25. Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis.
Vesterhus M; Holm A; Hov JR; Nygård S; Schrumpf E; Melum E; Thorbjørnsen LW; Paulsen V; Lundin K; Dale I; Gilja OH; Zweers SJLB; Vatn M; Schaap FG; Jansen PLM; Ueland T; Røsjø H; Moum B; Ponsioen CY; Boberg KM; Färkkilä M; Karlsen TH; Lund-Johansen F
J Hepatol; 2017 Jun; 66(6):1214-1222. PubMed ID: 28161472
[TBL] [Abstract][Full Text] [Related]
26. Validation, clinical utility and limitations of the Amsterdam-Oxford model for primary sclerosing cholangitis.
Goet JC; Floreani A; Verhelst X; Cazzagon N; Perini L; Lammers WJ; de Vries AC; van der Meer AJ; van Buuren HR; Hansen BE
J Hepatol; 2019 Nov; 71(5):992-999. PubMed ID: 31278949
[TBL] [Abstract][Full Text] [Related]
27. Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial.
Hirschfield GM; Chazouillères O; Drenth JP; Thorburn D; Harrison SA; Landis CS; Mayo MJ; Muir AJ; Trotter JF; Leeming DJ; Karsdal MA; Jaros MJ; Ling L; Kim KH; Rossi SJ; Somaratne RM; DePaoli AM; Beuers U
J Hepatol; 2019 Mar; 70(3):483-493. PubMed ID: 30414864
[TBL] [Abstract][Full Text] [Related]
28. ABCB4 mutations in adult patients with cholestatic liver disease: impact and phenotypic expression.
Degiorgio D; Crosignani A; Colombo C; Bordo D; Zuin M; Vassallo E; Syrén ML; Coviello DA; Battezzati PM
J Gastroenterol; 2016 Mar; 51(3):271-80. PubMed ID: 26324191
[TBL] [Abstract][Full Text] [Related]
29. Individuals with Primary Sclerosing Cholangitis Have Elevated Levels of Biomarkers for Apoptosis but Not Necrosis.
Masuoka HC; Vuppalanchi R; Deppe R; Bybee P; Comerford M; Liangpunsakul S; Ghabril M; Chalasani N
Dig Dis Sci; 2015 Dec; 60(12):3642-6. PubMed ID: 26195313
[TBL] [Abstract][Full Text] [Related]
30. Chronic cholestatic diseases.
Poupon R; Chazouillères O; Poupon RE
J Hepatol; 2000; 32(1 Suppl):129-40. PubMed ID: 10728800
[TBL] [Abstract][Full Text] [Related]
31. Copper, copper-binding protein and cytokeratin 7 in biliary disorders.
Quaglia A; Bhathal PS
Histopathology; 2017 Dec; 71(6):1006-1008. PubMed ID: 28722218
[No Abstract] [Full Text] [Related]
32. Evaluating distinctive features for early diagnosis of primary sclerosing cholangitis overlap syndrome in adults with autoimmune hepatitis.
Hunter M; Loughrey MB; Gray M; Ellis P; McDougall N; Callender M
Ulster Med J; 2011 Jan; 80(1):15-8. PubMed ID: 22347734
[TBL] [Abstract][Full Text] [Related]
33. The development and validation of magnetic resonance elastography for fibrosis staging in primary sclerosing cholangitis.
Jhaveri KS; Hosseini-Nik H; Sadoughi N; Janssen H; Feld JJ; Fischer S; Menezes R; Cheung AC
Eur Radiol; 2019 Feb; 29(2):1039-1047. PubMed ID: 30051141
[TBL] [Abstract][Full Text] [Related]
34. The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis.
Trauner M; Gulamhusein A; Hameed B; Caldwell S; Shiffman ML; Landis C; Eksteen B; Agarwal K; Muir A; Rushbrook S; Lu X; Xu J; Chuang JC; Billin AN; Li G; Chung C; Subramanian GM; Myers RP; Bowlus CL; Kowdley KV
Hepatology; 2019 Sep; 70(3):788-801. PubMed ID: 30661255
[TBL] [Abstract][Full Text] [Related]
35. The Natural History of Primary Sclerosing Cholangitis in Children: A Large Single-Center Longitudinal Cohort Study.
Valentino PL; Wiggins S; Harney S; Raza R; Lee CK; Jonas MM
J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):603-609. PubMed ID: 27504812
[TBL] [Abstract][Full Text] [Related]
36. [Cholestatic liver diseases].
Grimm D; Thimme R
Ther Umsch; 2011 Apr; 68(4):195-9. PubMed ID: 21452140
[TBL] [Abstract][Full Text] [Related]
37. Atrophic hepatocytes express keratin 7 in ischemia-associated liver lesions.
Delladetsima I; Sakellariou S; Kokkori A; Tiniakos D
Histol Histopathol; 2016 Oct; 31(10):1089-94. PubMed ID: 26887669
[TBL] [Abstract][Full Text] [Related]
38. Reduction in alkaline phosphatase is associated with longer survival in primary sclerosing cholangitis, independent of dominant stenosis.
Rupp C; Rössler A; Halibasic E; Sauer P; Weiss KH; Friedrich K; Wannhoff A; Stiehl A; Stremmel W; Trauner M; Gotthardt DN
Aliment Pharmacol Ther; 2014 Dec; 40(11-12):1292-301. PubMed ID: 25316001
[TBL] [Abstract][Full Text] [Related]
39. Eosinophilic cholangitis is a potentially underdiagnosed etiology in indeterminate biliary stricture.
Walter D; Hartmann S; Herrmann E; Peveling-Oberhag J; Bechstein WO; Zeuzem S; Hansmann ML; Friedrich-Rust M; Albert JG
World J Gastroenterol; 2017 Feb; 23(6):1044-1050. PubMed ID: 28246478
[TBL] [Abstract][Full Text] [Related]
40. Changes in liver stiffness using acoustic radiation force impulse imaging in patients with obstructive cholestasis and cholangitis.
Attia D; Pischke S; Negm AA; Rifai K; Manns MP; Gebel MJ; Lankisch TO; Potthoff A
Dig Liver Dis; 2014 Jul; 46(7):625-31. PubMed ID: 24666759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
